Thrombo-inflammation linking androgen suppression with cardiovascular risk in patients with prostate cancer

Antonia Beitzen-Heineke, David R. Wise, Jeffrey S. Berger

Open source

DOI
10.1186/s40959-024-00278-2
Published
2024-12-05
Container
Cardio-Oncology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s40959-024-00278-2,
  title = {Thrombo-inflammation linking androgen suppression with cardiovascular risk in patients with prostate cancer},
  author = {Antonia Beitzen-Heineke and David R. Wise and Jeffrey S. Berger},
  year = {2024},
  journal = {Cardio-Oncology},
  doi = {10.1186/s40959-024-00278-2},
  url = {https://doi.org/10.1186/s40959-024-00278-2}
}

RIS

TY  - JOUR
TI  - Thrombo-inflammation linking androgen suppression with cardiovascular risk in patients with prostate cancer
AU  - Antonia Beitzen-Heineke
AU  - David R. Wise
AU  - Jeffrey S. Berger
PY  - 2024
JO  - Cardio-Oncology
DO  - 10.1186/s40959-024-00278-2
UR  - https://doi.org/10.1186/s40959-024-00278-2
ER  - 

APA

Beitzen-Heineke, A., Wise, D. R., & Berger, J. S. (2024). Thrombo-inflammation linking androgen suppression with cardiovascular risk in patients with prostate cancer. Cardio-Oncology. https://doi.org/10.1186/s40959-024-00278-2

Source records